UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 29, 2014
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
|
|
|
|
|
|
|
400 West Cesar Chavez, Austin, TX |
|
78701 |
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On April 29, 2014, Silicon Laboratories Inc. (Silicon Laboratories) issued a press release describing its results of operations for its fiscal quarter ended March 29, 2014. A copy of the press release is attached as Exhibit 99 to this report.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
99 |
|
Press Release of Silicon Laboratories Inc. dated April 29, 2014 |
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.
Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The information in this report, including the exhibit hereto, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SILICON LABORATORIES INC. |
|
|
|
|
|
|
|
|
|
April 29, 2014 |
|
/s/ John C. Hollister |
Date |
|
John C. Hollister |
EXHIBIT INDEX
Exhibit No. |
|
Description |
99 |
|
Press Release of Silicon Laboratories Inc. dated April 29, 2014 |
Exhibit 99
SILICON LABS ANNOUNCES FIRST QUARTER 2014 RESULTS
Company Sees Growing Momentum in the Internet of Things
AUSTIN, Texas April 29, 2014 Silicon Labs (NASDAQ: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported financial results for its first quarter ended March 29, 2014. Revenue in the first quarter was at the top end of guidance at $145.7 million, compared with $146.2 million reported in the fourth quarter. Additionally, the company reported excellent performance on its balance sheet with strong cash flows and effective working capital management.
Q1 Financial Highlights
On a GAAP basis:
· Gross margin was 59.8 percent
· R&D expenses were $42.5 million
· SG&A expenses were $34.6 million
· Operating income as a percentage of revenue was 6.9 percent
· Diluted earnings per share were $0.18
On a non-GAAP basis (results exclude the impact of stock compensation, amortization from acquired intangible assets and certain other items as set forth in the reconciliation tables below):
· Gross margin was 60.2 percent
· R&D expenses were $35.0 million
· SG&A expenses were $28.5 million
· Operating income was 16.6 percent
· Diluted earnings per share were $0.42
Business Highlights
· Broad-based revenue was $72.3 million, essentially flat sequentially, as expected.
· Broadcast exceeded expectations with revenue of $50.7 million, including record revenue in video.
· Access revenue decreased slightly, as expected, to $22.7 million.
Product Highlights
· Introduced a new version of the Simplicity Studio development ecosystem supporting Silicon Labs MCU products in a single, unified platform, making the embedded design process easier, faster and more efficient.
· Announced the expansion of Silicon Labs Ember® ZigBee® portfolio with the introduction of a new ARM®-based system-on-a-chip family that reduces the cost and complexity of deploying ZigBee solutions in smart metering and home automation applications.
· Launched the industrys first single-chip digital ultraviolet (UV) index sensor ICs designed to track UV sun exposure, heart rate and blood oxygen levels for wearable products such as smart watches and health and fitness trackers.
· Acquired the full product portfolio and intellectual property of Silicon Valley-based Touchstone Semiconductor, an early-stage technology company and provider of low-power analog IC products targeting Internet of Things applications.
Business Outlook
The company expects revenue in the second quarter to be in the range of $147 million to $151 million. Second quarter diluted earnings per share are expected to be between $0.15 and $0.19 on a GAAP basis and between $0.43 and $0.47 on a non-GAAP basis. Both GAAP and non-GAAP estimates include an estimated $0.03 per share effect from litigation costs.
We continue to strengthen our position as a leading supplier of silicon solutions for the Internet of Things, said Tyson Tuttle, CEO of Silicon Labs. We expect this momentum to drive record Broad-based revenue in the second quarter.
Webcast and Conference Call
A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available simultaneously on Silicon Labs website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or (404) 537-3406 (international) and by entering 39717388. The replay will be available through May 29.
About Silicon Labs
Silicon Labs is an industry leader in the innovation of high-performance, analog-intensive, mixed-signal ICs. Developed by a world-class engineering team with unsurpassed expertise in mixed-signal design, Silicon Labs diverse portfolio of patented semiconductor solutions offers customers significant advantages in performance, size and power consumption. For more information about Silicon Labs, please visit www.silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs current expectations. The words believe, estimate, expect, intend, anticipate, plan, project, will and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements.
These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing our distributors, manufacturers and subcontractors; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs business and results of operations to risks of natural disasters, epidemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the Silicon Labs logo, Simplicity Studio and Ember are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Deborah Stapleton, +1 650.470.4200, Deborah.Stapleton@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
| ||||
|
|
March 29, |
|
March 30, |
| ||
Revenues |
|
$ |
145,691 |
|
$ |
145,375 |
|
Cost of revenues |
|
58,586 |
|
58,003 |
| ||
Gross margin |
|
87,105 |
|
87,372 |
| ||
Operating expenses: |
|
|
|
|
| ||
Research and development |
|
42,485 |
|
37,582 |
| ||
Selling, general and administrative |
|
34,611 |
|
29,153 |
| ||
Operating expenses |
|
77,096 |
|
66,735 |
| ||
Operating income |
|
10,009 |
|
20,637 |
| ||
Other income (expense): |
|
|
|
|
| ||
Interest income |
|
302 |
|
335 |
| ||
Interest expense |
|
(798 |
) |
(842 |
) | ||
Other income (expense), net |
|
67 |
|
(52 |
) | ||
Income before income taxes |
|
9,580 |
|
20,078 |
| ||
Provision for income taxes |
|
1,470 |
|
44 |
| ||
|
|
|
|
|
| ||
Net income |
|
$ |
8,110 |
|
$ |
20,034 |
|
|
|
|
|
|
| ||
Earnings per share: |
|
|
|
|
| ||
Basic |
|
$ |
0.19 |
|
$ |
0.47 |
|
Diluted |
|
$ |
0.18 |
|
$ |
0.46 |
|
|
|
|
|
|
| ||
Weighted-average common shares outstanding: |
|
|
|
|
| ||
Basic |
|
43,081 |
|
42,186 |
| ||
Diluted |
|
44,056 |
|
43,110 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
|
Three Months Ended |
| ||||||||||||||||||||
Non-GAAP Income |
|
GAAP |
|
GAAP |
|
Stock |
|
Intangible |
|
Termination |
|
Acquisition |
|
Non-GAAP |
|
Non- |
| ||||||
Revenues |
|
$ |
145,691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Gross margin |
|
87,105 |
|
59.8 |
% |
$ |
195 |
|
$ |
390 |
|
$ |
|
|
$ |
|
|
$ |
87,690 |
|
60.2 |
% | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Research and development |
|
42,485 |
|
29.2 |
% |
4,241 |
|
3,247 |
|
|
|
|
|
34,997 |
|
24.0 |
% | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Selling, general and administrative |
|
34,611 |
|
23.7 |
% |
4,841 |
|
729 |
|
(267 |
) |
816 |
|
28,492 |
|
19.6 |
% | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Operating income |
|
10,009 |
|
6.9 |
% |
9,277 |
|
4,366 |
|
(267 |
) |
816 |
|
24,201 |
|
16.6 |
% | ||||||
|
|
Three Months Ended |
| |||||||||||||||||||
Non-GAAP Diluted |
|
GAAP |
|
Stock |
|
Intangible |
|
Termination |
|
Acquisition |
|
Release of |
|
Non- |
| |||||||
Net income |
|
$ |
8,110 |
|
$ |
7,966 |
|
$ |
3,019 |
|
$ |
(199 |
) |
$ |
816 |
|
$ |
(1,292 |
) |
$ |
18,420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Diluted shares outstanding |
|
44,056 |
|
|
|
|
|
|
|
|
|
|
|
44,056 |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Diluted earnings per share |
|
$ |
0.18 |
|
|
|
|
|
|
|
|
|
|
|
$ |
0.42 |
| |||||
Unaudited Forward-Looking Statements Regarding Business Outlook
(In thousands, except per share information)
|
|
Three Months Ending |
| ||||
Business Outlook |
|
High |
|
Low |
| ||
Estimated GAAP diluted earnings per share |
|
$ |
0.19 |
|
$ |
0.15 |
|
|
|
|
|
|
| ||
Estimated non-GAAP charges |
|
0.28 |
|
0.28 |
| ||
|
|
|
|
|
| ||
Estimated non-GAAP diluted earnings per share |
|
$ |
0.47 |
|
$ |
0.43 |
|
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
|
|
March 29, |
|
December 28, |
| ||
Assets |
|
|
|
|
| ||
Current assets: |
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
128,323 |
|
$ |
95,800 |
|
Short-term investments |
|
194,765 |
|
179,593 |
| ||
Accounts receivable, net of allowances for doubtful accounts of $767 at March 29, 2014 and $797 at December 28, 2013 |
|
64,672 |
|
72,124 |
| ||
Inventories |
|
44,334 |
|
45,271 |
| ||
Deferred income taxes |
|
15,203 |
|
18,878 |
| ||
Prepaid expenses and other current assets |
|
40,214 |
|
47,651 |
| ||
Total current assets |
|
487,511 |
|
459,317 |
| ||
Long-term investments |
|
10,997 |
|
10,632 |
| ||
Property and equipment, net |
|
130,829 |
|
132,445 |
| ||
Goodwill |
|
228,781 |
|
228,781 |
| ||
Other intangible assets, net |
|
128,453 |
|
131,593 |
| ||
Other assets, net |
|
23,482 |
|
28,382 |
| ||
Total assets |
|
$ |
1,010,053 |
|
$ |
991,150 |
|
|
|
|
|
|
| ||
Liabilities and Stockholders Equity |
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
| ||
Accounts payable |
|
$ |
22,707 |
|
$ |
22,126 |
|
Current portion of long-term debt |
|
8,750 |
|
7,500 |
| ||
Accrued expenses |
|
67,745 |
|
45,975 |
| ||
Deferred income on shipments to distributors |
|
32,589 |
|
30,853 |
| ||
Income taxes |
|
1,330 |
|
2,693 |
| ||
Total current liabilities |
|
133,121 |
|
109,147 |
| ||
Long-term debt |
|
85,000 |
|
87,500 |
| ||
Other non-current liabilities |
|
30,737 |
|
55,941 |
| ||
Total liabilities |
|
248,858 |
|
252,588 |
| ||
Commitments and contingencies |
|
|
|
|
| ||
Stockholders equity: |
|
|
|
|
| ||
Preferred stock $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
|
|
|
|
| ||
Common stock $0.0001 par value; 250,000 shares authorized; 43,433 and 42,779 shares issued and outstanding at March 29, 2014 and December 28, 2013, respectively |
|
4 |
|
4 |
| ||
Additional paid-in capital |
|
62,883 |
|
48,630 |
| ||
Retained earnings |
|
698,722 |
|
690,612 |
| ||
Accumulated other comprehensive loss |
|
(414 |
) |
(684 |
) | ||
Total stockholders equity |
|
761,195 |
|
738,562 |
| ||
Total liabilities and stockholders equity |
|
$ |
1,010,053 |
|
$ |
991,150 |
|
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
|
Three Months Ended |
| ||||
|
|
March 29, |
|
March 30, |
| ||
Operating Activities |
|
|
|
|
| ||
Net income |
|
$ |
8,110 |
|
$ |
20,034 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
| ||
Depreciation of property and equipment |
|
3,290 |
|
3,297 |
| ||
Amortization of other intangible assets and other assets |
|
4,491 |
|
2,840 |
| ||
Stock-based compensation expense |
|
9,277 |
|
6,260 |
| ||
Income tax benefit (shortfall) from stock-based awards |
|
45 |
|
(363 |
) | ||
Excess income tax benefit from stock-based awards |
|
(235 |
) |
(217 |
) | ||
Deferred income taxes |
|
6,784 |
|
7,521 |
| ||
Changes in operating assets and liabilities: |
|
|
|
|
| ||
Accounts receivable |
|
7,452 |
|
5,256 |
| ||
Inventories |
|
1,083 |
|
(7,350 |
) | ||
Prepaid expenses and other assets |
|
14,266 |
|
4,620 |
| ||
Accounts payable |
|
1,195 |
|
2,356 |
| ||
Accrued expenses |
|
(2,218 |
) |
(4,330 |
) | ||
Deferred income on shipments to distributors |
|
1,736 |
|
(598 |
) | ||
Income taxes |
|
(8,324 |
) |
(9,818 |
) | ||
Net cash provided by operating activities |
|
46,952 |
|
29,508 |
| ||
|
|
|
|
|
| ||
Investing Activities |
|
|
|
|
| ||
Purchases of available-for-sale investments |
|
(43,366 |
) |
(78,851 |
) | ||
Proceeds from sales and maturities of available-for-sale investments |
|
28,242 |
|
25,674 |
| ||
Purchases of property and equipment |
|
(1,673 |
) |
(3,898 |
) | ||
Purchases of other assets |
|
(2,113 |
) |
(1,228 |
) | ||
Net cash used in investing activities |
|
(18,910 |
) |
(58,303 |
) | ||
|
|
|
|
|
| ||
Financing Activities |
|
|
|
|
| ||
Proceeds from issuance of common stock, net of shares withheld for taxes |
|
5,496 |
|
4,915 |
| ||
Excess income tax benefit from stock-based awards |
|
235 |
|
217 |
| ||
Payments on debt |
|
(1,250 |
) |
(2,500 |
) | ||
Net cash provided by financing activities |
|
4,481 |
|
2,632 |
| ||
|
|
|
|
|
| ||
Increase (decrease) in cash and cash equivalents |
|
32,523 |
|
(26,163 |
) | ||
Cash and cash equivalents at beginning of period |
|
95,800 |
|
105,426 |
| ||
Cash and cash equivalents at end of period |
|
$ |
128,323 |
|
$ |
79,263 |
|
###